Skip to main content

BHC

Stock
Health Care
Drug Manufacturers - Specialty & Generic

Performance overview

BHC Price
Price Chart

Forward-looking statistics

Beta
1.16
Risk
50.68%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Company info

SectorHealth Care
IndustryDrug Manufacturers - Specialty & Generic
Employees11K
Market cap$2.3B

Fundamentals

Enterprise value$23.8B
Revenue$9.7B
Revenue per employee—
Profit margin-0.41%
Debt to equity-89.63

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)-$0.12
Dividend per share$4.00
Revenue per share$26.39
Avg trading volume (30 day)$16M
Avg trading volume (10 day)$15M
Put-call ratio—

Macro factor sensitivity

Growth+4.4
Credit+1.1
Liquidity-2.4
Inflation+0.9
Commodities+0.3
Interest Rates-0.7

Valuation

Dividend yield56.66%
PEG Ratio1.60
Price to sales0.27
P/E Ratio1.60
Enterprise Value to Revenue2.44
Price to book-10.66

Upcoming events

Next earnings dayMay 1, 2025
Next dividend day—
Ex. dividend dayNovember 10, 2010

News

Why Is Bausch (BHC) Down 13% Since Last Earnings Report?

Bausch (BHC) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research (May 30, 2025)
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Wednesday.

Benzinga (March 26, 2025)
Bausch and Lomb CEO: Right on track with our important initiatives

Brent Saunders, Bausch and Lomb CEO, joins 'Money Movers' to discuss how Saunders has changed the portfolio in his time as chief executive, what the growth is like for Bausch and Lomb, and much more.

CNBC Television (January 14, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free